Last update 08 May 2025

VCB-1102

Overview

Basic Info

Drug Type
Natural Killer Cell Therapies
Synonyms
Autologous NK cells - Vaxcell Bio, Vax NK/HCC(Vaxcell-Bio Therapeutics), Vax-NK/HCC
+ [2]
Target-
Action-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [4]
Active Indication
Pancreatic CancerLocally Advanced Hepatocellular CarcinomaSmall Cell Lung Cancer+ [2]
Inactive Indication-
Originator Organization
Vaxcell-Bio TherapeuticsVaxcell-Bio Therapeutics
Active Organization
Vaxcell-Bio TherapeuticsVaxcell-Bio Therapeutics
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VCB-1102
NCT05040438
/ CompletedPhase 2
A Phase 2a Study Using Natural Killer (NK) Cell Therapy Combined With Hepatic Artery Infusion Chemotherapy (HAIC) in Patients With Locally Advanced Hepatocellular Carcinoma
100 Clinical Results associated with VCB-1102
Login to view more data
100 Translational Medicine associated with VCB-1102
Login to view more data
100 Patents (Medical) associated with VCB-1102
Login to view more data
100 Deals associated with VCB-1102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 2
South Korea
Vaxcell-Bio TherapeuticsVaxcell-Bio Therapeutics
03 Feb 2025
Locally Advanced Hepatocellular CarcinomaPhase 2
South Korea
Vaxcell-Bio TherapeuticsVaxcell-Bio Therapeutics
15 Oct 2019
Small Cell Lung CancerPhase 2
South Korea
Vaxcell-Bio TherapeuticsVaxcell-Bio Therapeutics
-
Multiple MyelomaDiscovery
South Korea
Vaxcell-Bio TherapeuticsVaxcell-Bio Therapeutics
30 Jan 2022
Prostatic CancerDiscovery
South Korea
Vaxcell-Bio TherapeuticsVaxcell-Bio Therapeutics
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free